Clinical Trials Directory

Trials / Unknown

UnknownNCT01697917

Impact on Quality of Life in Patients Undergoing Total Gastrectomy or Proximal Gastrectomy for Adenocarcinoma of Esophagogastric Junction

A Pilot Randomized Controlled Trial Examining the Differences of Quality of Life of Patients Undergoing Total Gastrectomy or Proximal Gastrectomy for Adenocarcinoma of Esophagogastric Junction

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
140 (estimated)
Sponsor
Fudan University · Academic / Other
Sex
All
Age
20 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to find out more about differences of the quality of life in patients undergoing total gastrectomy or proximal gastrectomy for adenocarcinoma of esophagogastric junction. To find a better reconstruction for patients who received total gastrectomy.

Detailed description

Overall, the incidence of stomach cancer worldwide is declining with geographical variation. However, an increase in the incidence rate of adenocarcinoma of esophagogastric junction, called cardia or AEG has been observed in recent years. AEG may represent a specific histopathological and biologic entity. In the treatment AEG there is argument over whether proximal gastractomy(PG) or total gastractomy (TG) should be done. The quality of life (QOL) of the patients following TG or PG arouses people's attention. The purpose of this study was to evaluate differences of the quality of life in patients undergoing total gastrectomy or proximal gastrectomy for adenocarcinoma of esophagogastric junction.

Conditions

Interventions

TypeNameDescription
OTHERTotal Gastrectomy or Proximal Gastrectomy

Timeline

Start date
2012-05-01
Primary completion
2015-05-01
Completion
2017-05-01
First posted
2012-10-02
Last updated
2012-10-02

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01697917. Inclusion in this directory is not an endorsement.